MXPA02007903A - Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres. - Google Patents

Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.

Info

Publication number
MXPA02007903A
MXPA02007903A MXPA02007903A MXPA02007903A MXPA02007903A MX PA02007903 A MXPA02007903 A MX PA02007903A MX PA02007903 A MXPA02007903 A MX PA02007903A MX PA02007903 A MXPA02007903 A MX PA02007903A MX PA02007903 A MXPA02007903 A MX PA02007903A
Authority
MX
Mexico
Prior art keywords
2minus
thiazolidinminus
methylminus
4minus
mtdc
Prior art date
Application number
MXPA02007903A
Other languages
English (en)
Inventor
Hans Rommelspacher
Original Assignee
Susilo Rudy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Susilo Rudy filed Critical Susilo Rudy
Publication of MXPA02007903A publication Critical patent/MXPA02007903A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

La invencion se refiere al uso de acido 2-metil-tiazolidina-2,4-dicarboxilico (2-MIDC) y/o sales fisiologicamente compatibles del mismo para tratar y/o prevenir canceres.
MXPA02007903A 2000-02-15 2001-02-15 Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres. MXPA02007903A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10008159A DE10008159B4 (de) 2000-02-15 2000-02-15 Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel
PCT/DE2001/000656 WO2001060343A2 (de) 2000-02-15 2001-02-15 Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen

Publications (1)

Publication Number Publication Date
MXPA02007903A true MXPA02007903A (es) 2004-09-10

Family

ID=7631906

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02007903A MXPA02007903A (es) 2000-02-15 2001-02-15 Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.

Country Status (15)

Country Link
US (2) US6943185B2 (es)
EP (1) EP1255538B1 (es)
JP (1) JP2003522782A (es)
CN (1) CN1400899A (es)
AT (1) ATE252383T1 (es)
AU (1) AU783933B2 (es)
CA (1) CA2399709C (es)
DE (2) DE10008159B4 (es)
EA (1) EA004592B1 (es)
ES (1) ES2208571T3 (es)
MX (1) MXPA02007903A (es)
PL (1) PL357179A1 (es)
PT (1) PT1255538E (es)
TR (1) TR200302134T4 (es)
WO (1) WO2001060343A2 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050197406A1 (en) * 1999-04-14 2005-09-08 Li Chiang J. Method of treatment of lung cancer
DE10008159B4 (de) * 2000-02-15 2005-08-18 Rudy Dr. Susilo Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel
RU2293721C2 (ru) * 2002-02-28 2007-02-20 Джапан Тобакко Инк. Сложноэфирные соединения и их применение в медицине
JP4832897B2 (ja) * 2003-08-29 2011-12-07 日本たばこ産業株式会社 エステル誘導体及びその医薬用途
DE102004021658A1 (de) * 2004-05-03 2005-12-01 Rudy Dr. Susilo Kombinationspräparate enthaltend 2-Methylthiazolidin-2,4-dicarbonsäure
US20060030623A1 (en) * 2004-07-16 2006-02-09 Noboru Furukawa Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis
US8101774B2 (en) * 2004-10-18 2012-01-24 Japan Tobacco Inc. Ester derivatives and medicinal use thereof
KR20070072888A (ko) * 2004-10-25 2007-07-06 니뽄 다바코 산교 가부시키가이샤 용해성 및 안정성이 개선된 고형 제제 및 그의 제조 방법
JP5439849B2 (ja) * 2008-02-28 2014-03-12 味の素株式会社 システイン誘導体
JP5378713B2 (ja) * 2008-06-19 2013-12-25 日本理化学薬品株式会社 外用組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19711053C2 (de) * 1997-03-03 1999-09-02 Rommelspacher Kombinationspräparat aus 2-Methyl-thiazolidin-2,4-dicarbonsäure und Paracetamol
DE19711052C2 (de) * 1997-03-03 1999-09-23 Hans Rommelspacher Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure als Mukolytikum
DE10008159B4 (de) * 2000-02-15 2005-08-18 Rudy Dr. Susilo Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel

Also Published As

Publication number Publication date
CN1400899A (zh) 2003-03-05
PT1255538E (pt) 2004-03-31
EA004592B1 (ru) 2004-06-24
EP1255538A2 (de) 2002-11-13
US6943185B2 (en) 2005-09-13
DE50100833D1 (de) 2003-11-27
WO2001060343A3 (de) 2002-05-30
TR200302134T4 (tr) 2004-01-21
DE10008159B4 (de) 2005-08-18
WO2001060343A2 (de) 2001-08-23
PL357179A1 (en) 2004-07-26
AU783933B2 (en) 2005-12-22
US20050187271A1 (en) 2005-08-25
CA2399709C (en) 2007-05-15
JP2003522782A (ja) 2003-07-29
AU3919001A (en) 2001-08-27
US20030149085A1 (en) 2003-08-07
DE10008159A1 (de) 2001-09-06
ATE252383T1 (de) 2003-11-15
ES2208571T3 (es) 2004-06-16
EA200200853A1 (ru) 2003-02-27
EP1255538B1 (de) 2003-10-22
CA2399709A1 (en) 2001-08-23

Similar Documents

Publication Publication Date Title
BG105783A (en) Triazole compounds with dopamine-d3-receptor affinity
HK1046403A1 (en) Nematicidal trifluorobutenes.
BG106586A (en) Pyrazolopyramidines as therapeutic agents
BG105270A (en) Tetrahydropyridoethers
BG107220A (en) Antitumoral ecteinascudin derivatives
MXPA03002911A (es) Compuestos quimicos.
IL153680A0 (en) Aplidine derivatives and methods for the preparation thereof
MY121864A (en) Condensed thienopyrimidines with phosphodiesterase-v inhibiting action.
MXPA02007903A (es) Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres.
SE9802937D0 (sv) Novel compounds
IL126235A (en) Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use
BG106031A (en) Prucalopride oral solution
GR1003490B (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν αλας παροξετινης
DK1100824T3 (da) Forbindelser med væksthormonfrigivende egenskaber
MXPA03008837A (es) Una composicion farmaceutica estable de pravastatina.
WO2002024181A3 (en) The use of melatonin for induction of general anesthesia
MD980129A (en) Antiherpetic remedy
AU7028798A (en) Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent
DE50006244D1 (en) Neue substituierte 3-phenoxy- und 3-phenylalkyloxy-2-phenyl-propylamine
ZA200201384B (en) 1,4-dioxacycloalkane-2-one and 1,4-dioxacyloalkene-2-one.
NO20012169L (no) Forbindelser med veksthormonfrigjörende egenskaper
ES2149691A1 (es) 2-4-[4-(4,5-dicloro-2metilimidazol-1-il)butil]-1-piperacinil -5-fluoropirimidina, su preparacion y su utilizacion terapeutica.
GR1003205B (el) Φαρμακοθεραπευτικες χρησεις δυο τετραυδροφουρανικων παραγωγων: τετραυδρο-ν,ν-διμεθυλ-5,5-διφαινυλ-3-φουρανομεθαναμινη (αε14) και τετραυδρο-ν,ν-διμεθυλ-2,2-διφαινυλ-3-φουρανομεθαναμινη (αε37)
UA32314A (uk) Спосіб лікування некротичного панкреатиту
MY134931A (en) Oral galantamine solution

Legal Events

Date Code Title Description
FG Grant or registration